Cano Health(CANO.US) rose 16.38 percent and sharply raised its 2022 profit guidance

2022-05-06 0 By

Glenexchange by Cano Health( rose 16.38% to $6.18 on March 15.The company today announced the results of the latest quarter, the US stock loss of 12 cents, more than the market expected 0.2 cents;Sales were $492.3 million, 7.4% below consensus of $531.65 million.The company expects full-year 2022 revenue of $2.8 billion to $2.9 billion, up from previous guidance of $2.6 billion to $2.7 billion and market expectations of $2.62 billion;Adjusted EBITDA was $230 million to $240 million, up from its previous forecast of $170 million to $175 million.The company also said it expects to be able to meet its 2022 guidance without the need for additional financing.